Sign inGet started

Fyfe Gwen A.

Insider CIK 1506217 · ARRY Director · INFI Director · CASC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3020,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3025,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3025,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3025,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3025,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3025,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3025,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer deriv2019-07-302019-07-3020,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer2019-07-302019-07-3015,000$48.00 $720.0K5,000SEC↗
ARRY ARRAY BIOPHARMA INC D To issuer2019-07-302019-07-305,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC M Exercise deriv2018-10-262018-10-295,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC M Exercise2018-10-262018-10-295,000— $015,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2018-10-252018-10-2925,000— $025,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2018-10-252018-10-295,000— $05,000SEC↗
CASC Cascadian Therapeutics, In D To issuer deriv2018-03-092018-03-1313,927— $00SEC↗
CASC Cascadian Therapeutics, In U Tender2018-03-092018-03-1310,125— $00SEC↗
ARRY ARRAY BIOPHARMA INC M Exercise deriv2017-10-272017-10-275,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC M Exercise2017-10-272017-10-275,000$10.47 $52.4K10,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2017-10-262017-10-275,000— $05,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2017-10-262017-10-2725,000— $025,000SEC↗
CASC Cascadian Therapeutics, In M Exercise deriv2017-06-242017-06-279,058— $00SEC↗
CASC Cascadian Therapeutics, In M Exercise2017-06-242017-06-279,058— $012,390SEC↗
CASC Cascadian Therapeutics, In F Tax w/h2017-06-242017-06-272,265$3.78 $8.6K10,125SEC↗
CASC Cascadian Therapeutics, In A Award deriv2017-06-092017-06-1313,927— $013,927SEC↗
CASC Cascadian Therapeutics, In P Buy2017-03-282017-03-301,666$4.12 $6.9K3,332SEC↗
ARRY ARRAY BIOPHARMA INC M Exercise deriv2016-10-292016-10-315,000— $00SEC↗
ARRY ARRAY BIOPHARMA INC M Exercise2016-10-292016-10-315,000$5.83 $29.1K5,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2016-10-272016-10-3125,000— $025,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2016-10-272016-10-315,000— $05,000SEC↗
CASC Cascadian Therapeutics, In A Award deriv2016-06-242016-06-2854,347— $054,347SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2015-10-292015-11-025,000— $05,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2015-10-292015-11-0225,000— $025,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2015-06-152015-06-1615,000— $015,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2014-10-302014-10-3125,000— $025,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2014-06-172014-06-1915,000— $015,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2013-10-232013-10-2425,000— $025,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2013-06-112013-06-1315,000— $015,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2012-10-242012-10-2620,000— $020,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2012-05-162012-05-186,000— $06,000SEC↗
INFI INFINITY PHARMACEUTICALS, A Award deriv2012-03-082012-03-1210,000— $010,000SEC↗
ARRY ARRAY BIOPHARMA INC A Award deriv2012-02-092012-02-0920,000$2.60 $52.0K20,000SEC↗